Genchrome
Commercial Due Diligence | BD Licensing | Market Access
A Trusted Advisor for Biotech, Pharma, and Investors
A leading advisory company, Genchrome stands as a trusted advisor for biotech, pharma, and investors, working closely with companies and VC firms to maximize the value of your assets and portfolio. With extensive experience as former big pharma executives, we ensure you are aligned with the evolving needs of pharma and market access, securing future growth and success.
Discover our expertise from preclinical to launch tailored to the needs of Biotech, Pharma and Investors.
Support for Biotech, Pharma, and Investors
What We Offer?
Genchrome provides the guidance and support you need to navigate complex fields like BD licensing, market access, and commercial due diligence. Whether you’re a biotech startup aiming for growth, a pharma looking to expand your portfolio, or an investor seeking promising opportunities, Genchrome is your trusted advisor for biotech, pharma, and investors.
From pre-clinical research to commercialization, we offer a full suite of services that ensures every phase of development is meticulously managed, reducing risks and increasing the potential for success. Our ability to understand both the scientific intricacies and the business aspects of the biotech and pharmaceutical industries sets us apart, ensuring your innovations achieve the impact they deserve.
Commercial Due Diligence
BD and M&A Support
Market Access Strategy
Pharma/Partnership
Business Plan - Launch Planning
TPP* Seeking
Benchmark Competitive Analysis
Our Consulting Approach
How we help?
At Genchrome, we recognize that transforming biotech innovations into successful therapies requires more than scientific expertise—it demands strategic foresight and business acumen. As your trusted partner for biotech, pharma, and investors, we leverage our team of former executives from leading pharmaceutical companies to guide you through each phase of development. With our expertise, you’ll have the insight needed to navigate the complexities of the life sciences industry.
Whether you’re a biotech startup, a pharma company, or an investor, our suite of services covers everything from pre-clinical research to product launch. At Genchrome, we’re dedicated to ensuring your innovations don’t just reach the market but deliver maximum impact and value.
Testimonials
What they say about us
“Genchrome’s expertise in orphan drugs was greatly valued at Lupin Neurosciences. We particularly acknowledge both the operational support to the build of our commercial organization and the market access activities we had for our Orphan Drug, Namuscla!”
Thierry Volle, President at Lupin Atlantis Holdings SA
“We appreciated Genchrome’s strategic support Fab’entech’s phase 1/2 FabenCov’ asset. Great competitive analysis, positioning and pricing expertise which generated great value to Fabentech . Genchrome also helped set up an EU/KOL scientific advisory board and identify potential pharmaceutical partners. This has helped to convince our board and BPI to add funds for the development of FabenCov.”
Sébastien Iva, CEO Fab’entech
“A deep understanding of each product market is essential. Genchrome helped us early on to analyze individual market mechanisms and identify relevant stakeholders as a basis to establish and challenge business case assumptions. It’s always been a pleasure to work with Genchrome’s senior industry experts.” | Scope: U.S/Canada/EU
Hannes Teissl , Chief Business Officer – Polpharma Biologics
“It was my pleasure to work with Caroline [Founder & CEO at Genchrome] at Amgen UK & Ireland where she built the commercial organisation for the launch of our range of Biosimilars and in particular laid the ground for the successful launch of Amgevita. Her deep customer insight derived from building excellent relationships with senior customers in the NHS proved invaluable not only to the launch in the UK but also in the rest of Europe.”
John Kearney, former VP Western Europe, Middle-East and Africa – Amgen
“Caroline [Founder & CEO at Genchrome] has a proven track record of translating high-level strategies into practical plans, validating ideas and executing successful go-to-market initiatives. Backed by her experience in product development and global markets, Caroline has been a great partner to support the launch of our medicines at Amgen.”
Philippe Legenne, VP clinical development and external scientific engagement – Molecular Partners
All logos, trade marks and brands are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trade marks, logos and brands does not imply endorsement.
Your Team of Trusted Advisors for Biotech, Pharma, and Investors
A Deep Expertise in the Life Science Sector
At Genchrome, we offer a wealth of expertise across the pharmaceutical and biotech industries. With decades of experience in drug development, regulatory affairs, clinical research, and commercialization, our team provides comprehensive support at every stage. As a trusted partner for biotech, pharma, and investors, we ensure that each phase of development and commercialization is managed with precision and deep insight.
By partnering with Genchrome, you gain access to unparalleled industry knowledge that helps overcome challenges and drives your innovative therapies to market success.